Director, Business Development @ (October 2024 - February 2026)
Associate Director, Business Development @ (March 2023 - September 2024)
Senior Manager, Corporate Development and Strategic Alliances @ (July 2022 - March 2023)
Senior Manager, Corporate Development @ (June 2022 - July 2022)
Business Development Manager @ (June 2021 - June 2022)
Patent Agent @ (February 2019 - March 2023)
Program Director, Translational Programs, Duke Innovation and Entrepreneurship @ (April 2020 - June 2021)
Innovation and Translation Fellow, Eshelman Institute for Innovation (EII) @ (February 2019 - April 2020)
Graduate Student, Biochemistry and Biophysics @ (August 2013 - February 2019)
Chemist II @ (January 2011 - May 2013)
Research Assistant @ (April 2009 - November 2009)
Russian Cryptologic Linguist @ (September 2003 - September 2008)
Andrew Lerner Education
Defense Language Institute Foreign Language Center
A (Russian)
University of California, Berkeley
BS (Chemistry)
UNC School of Medicine
Doctor of Philosophy - PhD (Biochemistry and Biophysics)
Andrew Lerner Summary
Andrew Lerner, based in Chapel Hill, NC, US, is currently a Director, Corporate Affairs and Investor Relations at Aktis Oncology. Andrew Lerner brings experience from previous roles at Aktis Oncology and StrideBio, Inc. Andrew Lerner holds a A in Russian @ Defense Language Institute Foreign Language Center. Andrew Lerner has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Andrew Lerner?
Find contact details for 700 million professionals.